Jeanluc Bertrand
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
New pyrimidine derivatives as potential agents against hepatocellular carcinoma: design, synthesis, and in vitro and in vivo biological evaluations.
Journal: Frontiers in pharmacology
Published: November 12, 2025
New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs.
Journal: Pharmaceutics
Published: April 08, 2024
New Smoothened ligands based on the purine scaffold as potential agents for treating pancreatic cancer.
Journal: Bioorganic chemistry
Published: March 28, 2024
In vitro and In vivo Biological Activity of Two Aryloxy-naphthoquinones in Mice Infected with Trypanosoma cruzi Strains.
Journal: Medicinal chemistry (Shariqah (United Arab Emirates))
Published: January 24, 2024
Mode of action of p-quinone derivatives with trypanocidal activity studied by experimental and in silico models.
Journal: European journal of medicinal chemistry
Published: September 16, 2022
Development of 3D-QSAR and pharmacophoric models to design new anti-Trypanosoma cruzi agents based on 2-aryloxynaphthoquinone scaffold.
Journal: SAR and QSAR in environmental research
Published: September 15, 2022
New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia.
Journal: Bioorganic chemistry
Published: September 17, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026